BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
May 16, 2003
View Archived Issues
Genentech's Asthma Product, Xolair, Receives FDA Panel Nod
An FDA advisory panel said Xolair appears to work well enough in moderate to severe allergic asthmatic patients to win regulatory approval. (BioWorld Today)
Read More
ID Biomedical Plans $22M Public Financing For Clinical Pipeline
Read More
Anglo-German Team Announces Genetic Molecular Basis Of Motor Neuron Diseases, Especially ALS
Read More
Chromos Enters Licensing Deal With CAT For Antibody Work
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More